Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou-Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells.

Biomedicines · 2025 · PMC11852490 · PMID 40002932

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Cisplatin and paclitaxel are two of the most prescribed therapeutic regimens, and reports have shown an increasing trend in treatment failure due to drug resistance [ 23 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.